1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA02387645
Considerations=specific to you: <=p> s=nbsp; We already have you using a new class of drugs not associated with the=risks measured in this study (Ambien/ zolpidem on days where you do not us= GHB). =/span>We should consider a sleep study which should measu=e: 1) sle=p architecture across 3 nights. (
No connected entities